Related Experiment Video
Updated: Jun 21, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Acromegalic myocardiopathy]
David Clemente Gallego1, Manuel Gómez Bueno, Tomás Lucas Morante
1Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta de Hierro, Madrid, Spain. davidclemente@aol.es
Insights
Acromegaly, a condition of excess growth hormone, often causes heart problems. Medical treatment for acromegaly successfully normalized heart function in a patient with dilated cardiomyopathy.
Area of Science:
- Endocrinology
- Cardiology
- Internal Medicine
Background:
- Acromegaly results from chronic growth hormone hypersecretion, leading to significant cardiovascular complications including hypertension and left ventricular hypertrophy.
- These cardiac issues are the primary cause of mortality in acromegaly patients.
- Effective management of acromegaly through surgery or pharmacotherapy can mitigate cardiovascular morbidity.
Observation:
- A 59-year-old woman with acromegaly presented with dilated cardiomyopathy.
- Her cardiac condition was monitored during medical treatment for acromegaly.
Findings:
- The patient experienced normalization of ventricular diameter and improved cardiac contractility.
- These positive changes were observed following medical treatment aimed at controlling growth hormone levels.
Implications:
- This case highlights the potential for reversing cardiac dysfunction in acromegaly patients with appropriate medical management.
- It underscores the importance of addressing growth hormone excess to improve cardiovascular outcomes.
- Further research into the specific mechanisms of cardiac recovery in acromegaly is warranted.
Abstract:
Acromegaly is characterized by chronic growth hormone hypersecretion. Cardiovascular alterations such as hypertension, left ventricular hypertrophy, cardiac rhythm disturbances and valvular disease are common in this disease and are the main cause of death. Control of acromegaly by surgery or pharmacotherapy has been shown to improve cardiovascular morbidity. We report a case of acromegalic myocardiopathy in a 59-year-old woman with dilated myocardiopathy who presented ventricular diameter and contractility normalization following medical treatment.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation I: Introduction

